From: Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
Indication
• Wet AMD
Clinical and imaging features
• Best-corrected visual acuity between 6/12 and 6/96
• Evidence of disease activity
• Absence of permanent structural damage to the central fovea
• Lesion size ≤ 12 disc areas